|
2026 Journal Article Cost savings associated with remission with mepolizumab in severe asthma: a cost comparison analysisHarvey, Erin S., McLoughlin, Rebecca F., Reeves, Penny, Dolja-Gore, Xenia, Thomas, Dennis, McDonald, Vanessa M., Fricker, Michael, Hamada, Yuto, Bardin, Philip, Peters, Matthew, Reynolds, Paul N., Upham, John W., Blakey, John, Bowler, Simon, Chien, Jimmy, Chung, Li Ping, Farah, Claude S., Gillman, Andrew, Harrington, John, Hew, Mark, Jenkins, Christine, Katelaris, Constance H., Katsoulotos, Gregory P., Kritikos, Vicky, Langton, David, Lee, Joy, Radhakrishna, Naghmeh, Wark, Peter A.B. and Gibson, Peter G. (2026). Cost savings associated with remission with mepolizumab in severe asthma: a cost comparison analysis. ERJ Open Research, 01813-2025. doi: 10.1183/23120541.01813-2025 |
|
2026 Journal Article Sustained clinical remission and relapse of severe eosinophilic asthma following long-term mepolizumab treatmentSabin Thomas, Rejoy, Thomas, Dennis, McDonald, Vanessa M., Harvey, Erin S., Bardin, Philip, Bowden, Jeffrey J., Bowler, Simon, Chien, Jimmy, Chung, Li Ping, Gillman, Andrew, Hew, Mark, Katelaris, Constance H., Katsoulotos, Gregory P., Langton, David, Lee, Joy, Upham, John W., Wark, Peter A.B., Fricker, Michael and Gibson, Peter G. (2026). Sustained clinical remission and relapse of severe eosinophilic asthma following long-term mepolizumab treatment. Allergology International. doi: 10.1016/j.alit.2026.05.003 |
|
2026 Journal Article A real-world controlled multicentre study evaluating the association between benralizumab therapy and major outcomes in severe asthmaThomas, Dennis, McDonald, Vanessa M., Thomas, Gijo, Lee, Joy, Chung, Li Ping, Peters, Matthew, Shukla, Shakti D., Hamada, Yuto, Harvey, Erin S., Fricker, Michael, See, Hayley, Sabin Thomas, Rejoy, Farah, Claude S., Gillman, Andrew, Katelaris, Constance H., Katsoulotos, Gregory P., Langton, David, Middleton, Peter G., Reynolds, Paul, Rimmer, Janet, Thien, Francis, Vincent, Stephen, Upham, John W. and Gibson, Peter G. (2026). A real-world controlled multicentre study evaluating the association between benralizumab therapy and major outcomes in severe asthma. Clinical and Experimental Allergy. doi: 10.1111/cea.70348 |
|
2025 Journal Article Finding cures for asthma: new paradigms for drug discovery and therapyZhuang, Aowen, Thomas, Dennis, Lodge, Caroline, Bourke, Jane E, Upham, John W, McDonald, Vanessa M, Wark, Peter AB and Anderson, Gary P (2025). Finding cures for asthma: new paradigms for drug discovery and therapy. Medical Journal of Australia, 223 (S10), S32-S35. doi: 10.5694/mja2.70089 |
|
2025 Journal Article Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumabHamada, Yuto, Thomas, Dennis, McDonald, Vanessa M., Harvey, Erin S., Fricker, Michael, Gillman, Andrew, Hew, Mark, Kritikos, Vicky, Upham, John W. and Gibson, Peter G. (2025). Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab. Annals of Allergy, Asthma and Immunology, 135 (5), 537-546.e12. doi: 10.1016/j.anai.2025.06.017 |
|
2025 Journal Article Association between hospitalised childhood pneumonia and follow-up chest radiographs in high-risk populations: a secondary analysis of a multicentre randomised controlled trialKok, Hing Cheong, Yerkovich, Stephanie T, McCallum, Gabrielle B, Grimwood, Keith, Masters, Ian Brent, Fancourt, Nicholas, Fong, Siew Moy, Nathan, Anna M, Byrnes, Catherine A, Ware, Robert S, Nachiappan, Nachal, Saari, Noorazlina, Morris, Peter S, Yeo, Tsin Wen, Oguoma, Victor M, de Bruyne, Jessie Anne, Eg, Kah Peng, Lee, Bilawara, Ooi, Mong How, Upham, John W, Torzillo, Paul J and Chang, Anne B (2025). Association between hospitalised childhood pneumonia and follow-up chest radiographs in high-risk populations: a secondary analysis of a multicentre randomised controlled trial. Archives of Disease in Childhood, 110 (10), 786-792. doi: 10.1136/archdischild-2024-328111 |
|
2025 Journal Article Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab RegistryHarvey, Erin S., Hamada, Yuto, Hiles, Sarah A., Langton, David, Thomas, Dennis, McDonald, Vanessa M., Bardin, Philip, Peters, Matthew, Reynolds, Paul N., Upham, John W., Blakey, John, Bowler, Simon, Chien, Jimmy, Chung, Li Ping, Farah, Claude S., Gillman, Andrew, Harrington, John, Hew, Mark, Jenkins, Christine, Katelaris, Constance H., Katsoulotos, Gregory P., Kritikos, Vicky, Lee, Joy, Radhakrishna, Naghmeh, Sivakumaran, Pathmanathan, Wark, Peter A.B. and Gibson, Peter G. (2025). Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry. Respiratory Medicine, 248 108340, 108340. doi: 10.1016/j.rmed.2025.108340 |
|
2025 Journal Article Impact of biologics initiation on oral corticosteroid use in the international severe asthma registry and the optimum patient care research database: a pooled analysis of real-world dataChen, Wenjia, Tran, Trung N., Townend, John, Christoff, George C., Tsai, Ming-Ju, Altraja, Alan, Cochrane, Belinda, Cosio, Borja G., Sivori, Martin, Murray, Ruth B., Makris, Michael P., Scelo, Ghislaine, Bulathsinhala, Lakmini, Ardusso, Ledit R.F., Franchi, María Eugenia, Máspero, Jorge, Saldarini, Fernando, Stok, Ana María, Tomaszuk, Ana Giselle, Yañez, Anahí, Emmanuel, Benjamin, Emmas, Cathy, Kostikas, Konstantinos, Menzies-Gow, Andrew N., Stjepanovic, Neda, Bosnic-Anticevich, Sinthia Z., Denton, Eve, Gibson, Peter G., Hew, Mark ... Price, David B. (2025). Impact of biologics initiation on oral corticosteroid use in the international severe asthma registry and the optimum patient care research database: a pooled analysis of real-world data. Journal of Allergy and Clinical Immunology: In Practice, 13 (8), 2033-2048. doi: 10.1016/j.jaip.2025.04.032 |
|
2025 Journal Article Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR)Schleich, Florence, Larenas-Linnemann, Désirée, Altraja, Alan, Pérez de Llano, Luis, Kostikas, Konstantinos, Sadatsafavi, Mohsen, Bourdin, Arnaud, Alton Pleasants, Roy, Hew, Mark, Chen, Wenjia, Jiménez-Maldonado, Libardo, Couillard, Simon, Suppli Ulrik, Charlotte, Bulkhi, Adeeb A., Tsai, Ming-Ju, Christoff, George C., Papadopoulos, Nikolaos G., Pfeffer, Paul E., Ryan, Dermot, Bergeron, Celine, Al-Ahmad, Mona S., Dorscheid, Delbert R., Wang, Eileen, Blakey, John D., Cochrane, Belinda, Peters, Matthew J., Popov, Todor A., Torres-Duque, Carlos A., Hansen, Susanne ... Price, David B. (2025). Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR). World Allergy Organization Journal, 18 (7) 101066. doi: 10.1016/j.waojou.2025.101066 |
|
2025 Journal Article Predicting future exacerbations in uncontrolled asthma: A discovery/validation approach using large-scale clinical proteomicsJurak, Lisa M., Yang, Ian A., Simpson, Jodie L., Gibson, Peter G., Hill, Michelle M. and Upham, John W. (2025). Predicting future exacerbations in uncontrolled asthma: A discovery/validation approach using large-scale clinical proteomics. Journal of Allergy and Clinical Immunology, 155 (6), 1846-1856.e2. doi: 10.1016/j.jaci.2025.02.028 |
|
2025 Journal Article Unlocking asthma remission: key insights from an expert roundtable discussionThomas, Dennis, Lewthwaite, Hayley, Gibson, Peter G., Majellano, Eleanor, Clark, Vanessa, Fricker, Michael, Hamada, Yuto, Anderson, Gary P., Backer, Vibeke, Bardin, Philip, Beasley, Richard, Chien, Jimmy, Farah, Claude S., Harrington, John, Harvey, Erin, Hew, Mark, Holland, Anne E., Jenkins, Christine, Katelaris, Constance H., Katsoulotos, Gregory, Murray, Kirsty, Peters, Matthew, Thomas, Rejoy, Tonga, Katrina, Upham, John W., Wark, Peter and McDonald, Vanessa M. (2025). Unlocking asthma remission: key insights from an expert roundtable discussion. Respirology, 30 (6), 466-479. doi: 10.1111/resp.70047 |
|
2025 Journal Article Early treatment response to mepolizumab predicts clinical remission in severe eosinophilic asthmaHamada, Yuto, Gibson, Peter G., Harvey, Erin S., Stevens, Sean, Lewthwaite, Hayley, Fricker, Michael, McDonald, Vanessa M., Gillman, Andrew, Hew, Mark, Kritikos, Vicky, Upham, John W. and Thomas, Dennis (2025). Early treatment response to mepolizumab predicts clinical remission in severe eosinophilic asthma. Journal of Allergy and Clinical Immunology: In Practice, 13 (2), 333-342. doi: 10.1016/j.jaip.2024.10.041 |
|
2025 Journal Article Experiences of oral corticosteroid use and adverse effects: a national cross-sectional survey of people with asthmaJones, Arwel W., Mcdonald, Vanessa M., Mcloughlin, Rebecca F., Vella, Teresa M., Flynn, Anthony W., Blakey, John, Wolfenden, Luke, Hew, Mark, Upham, John W., Thomas, Dennis, Bardin, Philip and Holland, Anne E. (2025). Experiences of oral corticosteroid use and adverse effects: a national cross-sectional survey of people with asthma. Patient Preference and Adherence, 19, 75-85. doi: 10.2147/PPA.S487743 |
|
2025 Journal Article Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthmaHamada, Yuto, Thomas, Dennis, Harvey, Erin S., Stevens, Sean, Fricker, Michael, Lewthwaite, Hayley, McDonald, Vanessa M., Gillman, Andrew, Hew, Mark, Kritikos, Vicky, Upham, John W. and Gibson, Peter G. (2025). Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma. The European Respiratory Journal, 65 (1) 2400782, 1-13. doi: 10.1183/13993003.00782-2024 |
|
2024 Journal Article Patient-centred composite scores as tools for assesment of response to biological therapy for paediatric and adult severe asthmaKhaleva, Ekaterina, Brightling, Chris, Eiwegger, Thomas, Altraja, Alan, Bégin, Philippe, Blumchen, Katharina, Bossios, Apostolos, Bourdin, Arnaud, Ten Brinke, Anneke, Brusselle, Guy, Silvia Bumbacea, Roxana, Bush, Andrew, Casale, Thomas B, Clarke, Graham W., Chaudhuri, Rekha, Fan Chung, Kian, Coleman, Courtney, Corren, Jonathan, Dahlén, Sven-Erik, Deschildre, Antoine, Djukanovic, Ratko, Eger, Katrien, Exley, Andrew, Fleming, Louise, Fowler, Stephen J., Gaillard, Erol A., Gappa, Monika, Gupta, Atul, Michael Haitchi, Hans ... on behalf of the 3TR Asthma Definition of Response Working Group (2024). Patient-centred composite scores as tools for assesment of response to biological therapy for paediatric and adult severe asthma. European Respiratory Journal, 65 (3) 2400691, 1-18. doi: 10.1183/13993003.00691-2024 |
|
2024 Journal Article Exploring definitions and predictors of severe asthma clinical remission after biologic treatment in adultsPerez-De-Llano, Luis, Scelo, Ghislaine, Tran, Trung N., Le, Tham T., Fagerås, Malin, Cosio, Borja G., Peters, Matthew, Pfeffer, Paul E., Al-Ahmad, Mona, Al-Lehebi, Riyad O., Altraja, Alan, Bergeron, Celine, Bjermer, Leif H., Bjerrum, Anne S., Bulathsinhala, Lakmini, Busby, John, Cano Rosales, Diana J., Canonica, Giorgio W., Carter, Victoria A., Charriot, Jeremy, Christoff, George C., Denton, Eve J., Dorscheid, Delbert R., Fernandez Sanchez, Maria J., Fonseca, João A., Gibson, Peter G., Goh, Celine Y.Y., Heaney, Liam G., Heffler, Enrico ... Price, David B. (2024). Exploring definitions and predictors of severe asthma clinical remission after biologic treatment in adults. American Journal of Respiratory and Critical Care Medicine, 210 (7), 869-880. doi: 10.1164/rccm.202311-2192OC |
|
2024 Journal Article Exploring definitions and predictors of response to biologics for severe asthmaScelo, Ghislaine, Tran, Trung N., Le, Tham T., Fagerås, Malin, Dorscheid, Delbert, Busby, John, Al-Ahmad, Mona, Al-Lehebi, Riyad, Altraja, Alan, Beastall, Aaron, Bergeron, Celine, Bjermer, Leif, Bjerrum, Anne S., Cano-Rosales, Diana Jimena, Canonica, Giorgio Walter, Carter, Victoria, Charriot, Jeremy, Christoff, George C., Cosio, Borja G., Denton, Eve, Fernandez-Sanchez, Maria Jose, Fonseca, João A., Gibson, Peter G., Goh, Celine, Heaney, Liam G., Heffler, Enrico, Hew, Mark, Iwanaga, Takashi, Katial, Rohit ... Price, David B. (2024). Exploring definitions and predictors of response to biologics for severe asthma. Journal of Allergy and Clinical Immunology: In Practice, 12 (9), 2347-2361. doi: 10.1016/j.jaip.2024.05.016 |
|
2024 Journal Article Real-world biologics response and super-response in the International Severe Asthma Registry cohortDenton, Eve, Hew, Mark, Peters, Matthew J., Upham, John W., Bulathsinhala, Lakmini, Tran, Trung N., Martin, Neil, Bergeron, Celine, Al-Ahmad, Mona, Altraja, Alan, Larenas-Linnemann, Desiree, Murray, Ruth, Celis-Preciado, Carlos Andres, Al-Lehebi, Riyad, Belhassen, Manon, Bhutani, Mohit, Bosnic-Anticevich, Sinthia Z., Bourdin, Arnaud, Brusselle, Guy G., Busby, John, Canonica, Giorgio Walter, Heffler, Enrico, Chapman, Kenneth R., Charriot, Jeremy, Christoff, George C., Chung, Li Ping, Cosio, Borja G., Cote, Andreanne, Costello, Richard W. ... Price, David B. (2024). Real-world biologics response and super-response in the International Severe Asthma Registry cohort. Allergy, 79 (10), 2700-2716. doi: 10.1111/all.16178 |
|
2024 Journal Article Twenty-four month outcomes of extended- versus standard-course antibiotic therapy in children hospitalized with pneumonia in high-risk settings: a randomized controlled trialKok, Hing C., McCallum, Gabrielle B., Yerkovich, Stephanie T., Grimwood, Keith, Fong, Siew M., Nathan, Anna M., Byrnes, Catherine A., Ware, Robert S., Nachiappan, Nachal, Saari, Noorazlina, Morris, Peter S., Yeo, Tsin W., Oguoma, Victor M., Masters, I. Brent, de Bruyne, Jessie A., Eg, Kah P., Lee, Bilawara, Ooi, Mong H., Upham, John W., Torzillo, Paul J. and Chang, Anne B. (2024). Twenty-four month outcomes of extended- versus standard-course antibiotic therapy in children hospitalized with pneumonia in high-risk settings: a randomized controlled trial. Pediatric Infectious Disease Journal, 43 (9), 872-879. doi: 10.1097/inf.0000000000004407 |
|
2024 Journal Article Biologics (mepolizumab and omalizumab) induced remission in severe asthma patientsThomas, Dennis, McDonald, Vanessa M., Stevens, Sean, Harvey, Erin S., Baraket, Melissa, Bardin, Philip, Bowden, Jeffrey J., Bowler, Simon, Chien, Jimmy, Chung, Li Ping, Gillman, Andrew, Hew, Mark, Hodge, Sandra, James, Alan, Jenkins, Christine, Katelaris, Constance H., Katsoulotos, Gregory P., Langton, David, Lee, Joy, Marks, Guy, Peters, Matthew, Radhakrishna, Naghmeh, Reynolds, Paul N., Rimmer, Janet, Sivakumaran, Pathmanathan, Upham, John W., Wark, Peter, Yang, Ian A. and Gibson, Peter G. (2024). Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients. Allergy, 79 (2), 384-392. doi: 10.1111/all.15867 |
